Trogenix
PrivateLast Round
Series A
Oct 6, 2025
Total Funding Raised
$114M
Momentum Score
50 /100
Company Overview
Trogenix is a biotechnology company that develops precision cancer treatments using its proprietary Odysseus® genetic medicine platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trogenix Comps
Public and private peers based on sector, stage, and business model.
Trogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 6, 2025 | ||||
| Seed | Nov 18, 2024 |
Key People
Founding team and executive leadership
Trogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 4Bio Capital | Series A, Seed |
| Meltwind Advisory | Series A |
| IQ Capital | Seed, Series A |
| LongeVC | Series A |
| Old College Capital | Seed |
| Calculus Capital | Series A |
| Cancer Research Horizons | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Grew 33% QoQ, from 12 to 16 employees.
- Oct 14, 2025
Grew 25% QoQ from 12 to 15 employees.
Trogenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trogenix's valuation, stock price, and market status.
